AU2002223626A1 - Combinations of a thyromimetic compound and a statin - Google Patents

Combinations of a thyromimetic compound and a statin

Info

Publication number
AU2002223626A1
AU2002223626A1 AU2002223626A AU2362602A AU2002223626A1 AU 2002223626 A1 AU2002223626 A1 AU 2002223626A1 AU 2002223626 A AU2002223626 A AU 2002223626A AU 2362602 A AU2362602 A AU 2362602A AU 2002223626 A1 AU2002223626 A1 AU 2002223626A1
Authority
AU
Australia
Prior art keywords
statin
combinations
thyromimetic compound
thyromimetic
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002223626A
Inventor
Beatriz N. Dardik
Ronald Edward Steele
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2002223626A1 publication Critical patent/AU2002223626A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
AU2002223626A 2000-10-20 2001-10-18 Combinations of a thyromimetic compound and a statin Abandoned AU2002223626A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24203600P 2000-10-20 2000-10-20
US60/242,036 2000-10-20
PCT/EP2001/012075 WO2002032408A2 (en) 2000-10-20 2001-10-18 Combinations of a thyromimetic compound and a statin

Publications (1)

Publication Number Publication Date
AU2002223626A1 true AU2002223626A1 (en) 2002-04-29

Family

ID=22913212

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002223626A Abandoned AU2002223626A1 (en) 2000-10-20 2001-10-18 Combinations of a thyromimetic compound and a statin

Country Status (2)

Country Link
AU (1) AU2002223626A1 (en)
WO (1) WO2002032408A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1262177E (en) * 2001-05-31 2006-12-29 Pfizer Prod Inc Medical use of thyromimetic compounds to treat hair loss and compositions
GEP20084540B (en) 2003-01-14 2008-11-25 Arena Pharm Inc 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
KR20060056944A (en) 2003-07-14 2006-05-25 아레나 파마슈티칼스, 인크. Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
AU2004293013B2 (en) 2003-11-19 2011-04-28 Metabasis Therapeutics, Inc. Novel phosphorus-containing thyromimetics
KR100927563B1 (en) 2004-08-06 2009-11-23 오쓰까 세이야꾸 가부시키가이샤 Aromatic compounds
JP2008542301A (en) 2005-05-26 2008-11-27 メタバシス・セラピューティクス・インコーポレイテッド Thyroid hormone-like drug for the treatment of fatty liver disease
MY146514A (en) 2005-12-05 2012-08-15 Otsuka Pharma Co Ltd Diarylether derivatives as antitumor agents
CN100371709C (en) * 2005-12-12 2008-02-27 重庆医药工业研究院有限责任公司 Method for separating and determining pitavastatin and its optical isomer by means of liquid chromatography
UA95978C2 (en) 2006-10-02 2011-09-26 Оцука Фармас'Ютікел Ко., Лтд. Stat3/5 activation inhibitor
CN103221410B (en) 2010-09-22 2017-09-15 艾尼纳制药公司 GPR119 receptor modulators and the treatment to relative obstacle
NZ734220A (en) 2015-01-06 2022-01-28 Arena Pharm Inc Methods of treating conditions related to the s1p1 receptor
IL285890B (en) 2015-06-22 2022-07-01 Arena Pharm Inc Crystalline free-plate habit of l-arginine salt of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid
BR112019010249A2 (en) 2016-11-21 2019-09-10 Viking Therapeutics Inc glycogen storage disease treatment method
JP2020507611A (en) 2017-02-16 2020-03-12 アリーナ ファーマシューティカルズ， インコーポレイテッド Compounds and methods for the treatment of primary biliary cholangitis
EA201992703A1 (en) 2017-06-05 2020-04-15 Вайкинг Терапьютикс, Инк. COMPOSITIONS FOR TREATING FIBROSIS
US11787828B2 (en) 2018-03-22 2023-10-17 Viking Therapeutics, Inc. Crystalline forms and methods of producing crystalline forms of a compound

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL144765A0 (en) * 1999-03-01 2002-06-30 Pfizer Prod Inc Oxamic acids and derivatives as thyroid receptor ligands
CO5160290A1 (en) * 1999-03-29 2002-05-30 Novartis Ag DERIVATIVES OF REPLACED PHENOXYPHENYLOXAMIC ACID.

Also Published As

Publication number Publication date
WO2002032408A3 (en) 2003-10-02
WO2002032408A2 (en) 2002-04-25

Similar Documents

Publication Publication Date Title
AU2001294009A1 (en) Methods of providing java tamperproofing
AU6820000A (en) Novel proteases and variants thereof
AU2001261630A1 (en) Audio closure
AU2002223626A1 (en) Combinations of a thyromimetic compound and a statin
AU2001280599A1 (en) Compounds and methods
AU2001253418A1 (en) Compounds and methods
AU2001266345A1 (en) Five-membered-ring compound
AU2001292732A1 (en) Beta-lactam analogs and uses therefor
AU2002367427A1 (en) Biaryl compound and use thereof
AU2001243394A1 (en) Compounds and methods
AU3035600A (en) Combination of cerivastatin and fibrates
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001283085A1 (en) Synergistic effect of amlodipine and atorvastatin
AU2001228662A1 (en) Hyperpolarization of a gas
AUPQ872300A0 (en) Compounds and methods
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2001264863A1 (en) Preparation of fagopyritols and uses therefor
AU2001278951A1 (en) Compounds and methods
AU2002235277A1 (en) Compounds and methods
AUPQ575300A0 (en) New compound
AU2002251543A1 (en) Novel atisane compound and use thereof
AU2000274552A1 (en) An open construction of a can
AU2001239631A1 (en) A new oligomer compound and a use thereof
AU2001258330A1 (en) New uses of imidazolylmethyl-pyridines
EP1357928A4 (en) A novel pharmaceutical compound and methods of making and using same